IN BRIEF: IQ-AI launches IB Clinic on Bayer Calantic platform

Archived article

Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.

IQ-AI Ltd - Jersey-based medical services firm - Says its medical imaging analysis software, IB Clinic, is now available via the newly launched Bayer Calantic platform. The distribution partnership continues its strategy of making IB Clinic accessible to healthcare providers through widespread networks, the company adds.

IQ-AI CEO Trevor Brown comments: ‘Whilst it is too soon to predict the revenue impact of this new partnership, we are hopeful that it marks a significant expansion of availability globally.’

Current stock price: 3.35 pence each, down 7.6% on Monday

12-month change: down 58%

Copyright 2022 Alliance News Limited. All Rights Reserved.